跳至主要内容
临床试验/NL-OMON46281
NL-OMON46281招募中不适用

Therap-i: A personalized monitoring and feedback tool as an add-on to support standard treatment for depression. - Therap-i

niversitair Medisch Centrum Groningen0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Main diagnosis is Major Depressive Disorder (MDD) according to the DSM-V
  • - Age between 18-65 years
  • - Patients have previously received a primary protocolled psychological/psychotherapeutic intervention for depression, consisting of four months of (cognitive) behavioural therapy, interpersonal therapy or brief psychodynamic therapy, which is evaluated as not effective (enough) to repeat or continue by the clinician responsible for the patient.
  • - Patients start or receive policlinic psychological treatment wherein they have weekly one-on-one consults with a therapist for at least 8 weeks

排除标准

  • - A current diagnosis of:
  • * MDD with psychotic features
  • * bipolar disorder
  • * substance-related and addictive disorder
  • * schizophrenia spectrum and other psychotic disorder
  • * neurocognitive disorder
  • - Previous treatment with Electroconvulsive Therapy
  • - Visual impairments that cannot be corrected
  • - Insufficient mastery of the Dutch language
  • - Inability or unwillingness to manage a smartphone

研究者

相似试验

Therap-i: A personalized monitoring and feedback... | 临床试验